Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Mechanisms of natural brassinosteroid-induced apoptosis of prostate cancer cells

Jana Steigerová, Lucie Rárová, Jana Oklešt'ková, Kateřina Křížová, Monika Levková, Michaela Šváchová, Zdeněk Kolář, Miroslav Strnad

. 2012 ; 50 (11) : 4068-4076.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13024327

Grantová podpora
NT11060 MZ0 CEP - Centrální evidence projektů

Brassinosteroids (BRs) are a group of polyhydroxylated sterol derivatives with important regulatory roles in various plant physiological processes. The aim of this study was to examine the mechanism of the antiproliferative activity of natural BRs 28-homocastasterone (28-homoCS) and 24-epibrassinolide (24-epiBL) in hormone-sensitive and -insensitive (LNCaP and DU-145, respectively) human prostate cancer cell lines. The effects of BRs on prostate cancer cells were surveyed using flow cytometry, Western blotting, TUNEL, DNA ladder assays and immunofluorescence analyses. The studied BRs inhibited cell growth and induced G(1) blocks in LNCaP cells accompanied by reductions in cyclin D(1), CDK4/6 and pRb expression. Following BR treatment of DU-145 cells, increases in proportions of cells in the G(2)/M phase of cell cycle were observed, accompanied by down-regulation of cyclins A and B(1). Changes in AR localization patterns in LNCaP cells treated with BRs were shown by immunofluorescence analysis. Furthermore, apoptotic detection methods demonstrated induction of apoptosis mediated by BRs in both cell lines, although changes in the expression of apoptosis-related proteins were modulated differently by 28-homoCS and 24-piBL in each cell line. The studied BRs seem to exert potent growth inhibitory and pro-apoptotic effects and could be therefore highly valuable new candidates for prostate anticancer drugs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13024327
003      
CZ-PrNML
005      
20141112141512.0
007      
ta
008      
130703s2012 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.fct.2012.08.031 $2 doi
035    __
$a (PubMed)22939933
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Steigerová, Jana $u Laboratory of Molecular Pathology, Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic; Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry, Palacký University and Faculty Hospital in Olomouc, Olomouc, Czech Republic. jana.steigerova@seznam.cz
245    10
$a Mechanisms of natural brassinosteroid-induced apoptosis of prostate cancer cells / $c Jana Steigerová, Lucie Rárová, Jana Oklešt'ková, Kateřina Křížová, Monika Levková, Michaela Šváchová, Zdeněk Kolář, Miroslav Strnad
520    9_
$a Brassinosteroids (BRs) are a group of polyhydroxylated sterol derivatives with important regulatory roles in various plant physiological processes. The aim of this study was to examine the mechanism of the antiproliferative activity of natural BRs 28-homocastasterone (28-homoCS) and 24-epibrassinolide (24-epiBL) in hormone-sensitive and -insensitive (LNCaP and DU-145, respectively) human prostate cancer cell lines. The effects of BRs on prostate cancer cells were surveyed using flow cytometry, Western blotting, TUNEL, DNA ladder assays and immunofluorescence analyses. The studied BRs inhibited cell growth and induced G(1) blocks in LNCaP cells accompanied by reductions in cyclin D(1), CDK4/6 and pRb expression. Following BR treatment of DU-145 cells, increases in proportions of cells in the G(2)/M phase of cell cycle were observed, accompanied by down-regulation of cyclins A and B(1). Changes in AR localization patterns in LNCaP cells treated with BRs were shown by immunofluorescence analysis. Furthermore, apoptotic detection methods demonstrated induction of apoptosis mediated by BRs in both cell lines, although changes in the expression of apoptosis-related proteins were modulated differently by 28-homoCS and 24-piBL in each cell line. The studied BRs seem to exert potent growth inhibitory and pro-apoptotic effects and could be therefore highly valuable new candidates for prostate anticancer drugs.
650    _2
$a fytogenní protinádorové látky $x farmakologie $7 D000972
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a brassinosteroidy $x farmakologie $7 D060406
650    _2
$a buněčný cyklus $x účinky léků $7 D002453
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a cholestanony $x farmakologie $7 D002778
650    _2
$a cyklin D1 $x metabolismus $7 D019938
650    _2
$a cyklin-dependentní kinasa 4 $x metabolismus $7 D051358
650    _2
$a cyklin-dependentní kinasa 6 $x metabolismus $7 D051361
650    _2
$a screeningové testy protinádorových léčiv $7 D004354
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a nádory prostaty $x farmakoterapie $x metabolismus $x patologie $7 D011471
650    _2
$a androgenní receptory $x metabolismus $7 D011944
650    _2
$a receptory pro estrogeny $x metabolismus $7 D011960
650    _2
$a steroidy heterocyklické $x farmakologie $7 D013260
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rárová, Lucie $u Centre of the Region Haná for Biotechnological and Agricultural Research, Department of Growth Regulators, Faculty of Science, Palacký University, Olomouc, Czech Republic
700    1_
$a Oklešt'ková, Jana $u Laboratory of Growth Regulators, Institute of Experimental Botany ASCR & Palacký University, Olomouc, Czech Republic
700    1_
$a Křížová, Kateřina $u Laboratory of Molecular Pathology, Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic
700    1_
$a Levková, Monika $u Laboratory of Molecular Pathology, Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic; Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry, Palacký University and Faculty Hospital in Olomouc, Olomouc, Czech Republic
700    1_
$a Sváchová, Michaela $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Kolář, Zdeněk $u Laboratory of Molecular Pathology, Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic; Institute of Molecular and Translation Medicine, Faculty of Medicine and Dentistry, Palacký University and Faculty Hospital in Olomouc, Olomouc, Czech Republic
700    1_
$a Strnad, Miroslav $u Centre of the Region Haná for Biotechnological and Agricultural Research, Department of Growth Regulators, Faculty of Science, Palacký University, Olomouc, Czech Republic; Laboratory of Growth Regulators, Institute of Experimental Botany ASCR & Palacký University, Olomouc, Czech Republic
773    0_
$w MED00001825 $t Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association $x 1873-6351 $g Roč. 50, č. 11 (2012), s. 4068-4076
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22939933 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20141112141525 $b ABA008
999    __
$a ok $b bmc $g 988007 $s 822707
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 50 $c 11 $d 4068-4076 $i 1873-6351 $m Food and chemical toxicology $n Food Chem Toxicol $x MED00001825
GRA    __
$a NT11060 $p MZ0
LZP    __
$a Pubmed-20130703

Najít záznam

Citační ukazatele

Možnosti archivace